Logo image of CRBN.AS

CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock

18.88 EUR
-0.34 (-1.77%)
Last: 1/20/2026, 4:15:41 PM
Fundamental Rating

5

Overall CRBN gets a fundamental rating of 5 out of 10. We evaluated CRBN against 69 industry peers in the Chemicals industry. CRBN has an average financial health and profitability rating. CRBN has a bad growth rate and is valued cheaply. These ratings could make CRBN a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year CRBN was profitable.
  • In the past year CRBN had a positive cash flow from operations.
  • Each year in the past 5 years CRBN has been profitable.
  • CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • CRBN has a Return On Assets of 4.57%. This is in the better half of the industry: CRBN outperforms 69.57% of its industry peers.
  • CRBN has a Return On Equity of 9.14%. This is in the better half of the industry: CRBN outperforms 68.12% of its industry peers.
  • CRBN has a better Return On Invested Capital (9.22%) than 76.81% of its industry peers.
  • CRBN had an Average Return On Invested Capital over the past 3 years of 6.62%. This is in line with the industry average of 6.70%.
  • The 3 year average ROIC (6.62%) for CRBN is below the current ROIC(9.22%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CRBN has a better Profit Margin (5.12%) than 65.22% of its industry peers.
  • CRBN's Profit Margin has improved in the last couple of years.
  • CRBN has a better Operating Margin (8.70%) than 62.32% of its industry peers.
  • In the last couple of years the Operating Margin of CRBN has declined.
  • CRBN's Gross Margin of 26.10% is on the low side compared to the rest of the industry. CRBN is outperformed by 62.32% of its industry peers.
  • CRBN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRBN is creating some value.
  • CRBN has less shares outstanding than it did 1 year ago.
  • CRBN has less shares outstanding than it did 5 years ago.
  • CRBN has a better debt/assets ratio than last year.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.78 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CRBN has a better Altman-Z score (2.78) than 60.87% of its industry peers.
  • CRBN has a debt to FCF ratio of 4.92. This is a neutral value as CRBN would need 4.92 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.92, CRBN is doing good in the industry, outperforming 73.91% of the companies in the same industry.
  • A Debt/Equity ratio of 0.39 indicates that CRBN is not too dependend on debt financing.
  • The Debt to Equity ratio of CRBN (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.78
ROIC/WACC1.39
WACC6.64%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 1.21 indicates that CRBN should not have too much problems paying its short term obligations.
  • CRBN has a Current ratio of 1.21. This is in the lower half of the industry: CRBN underperforms 79.71% of its industry peers.
  • CRBN has a Quick Ratio of 1.21. This is a bad value and indicates that CRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.60, CRBN is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

  • CRBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.92%.
  • The Earnings Per Share has been growing by 49.47% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 2.95% in the past year.
  • CRBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.70% yearly.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
  • The Revenue is expected to decrease by -1.71% on average over the next years.
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.86, the valuation of CRBN can be described as correct.
  • Based on the Price/Earnings ratio, CRBN is valued a bit cheaper than the industry average as 71.01% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.38. CRBN is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 12.41, the valuation of CRBN can be described as correct.
  • 82.61% of the companies in the same industry are more expensive than CRBN, based on the Price/Forward Earnings ratio.
  • CRBN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.86
Fwd PE 12.41
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 66.67% of the companies in the same industry are more expensive than CRBN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CRBN is valued cheaply inside the industry as 94.20% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.95
EV/EBITDA 7.98
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CRBN has a very decent profitability rating, which may justify a higher PE ratio.
  • CRBN's earnings are expected to grow with 19.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)0.34
EPS Next 2Y22.97%
EPS Next 3Y19.62%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.29%, CRBN has a reasonable but not impressive dividend return.
  • CRBN's Dividend Yield is a higher than the industry average which is at 2.33.
  • CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 3.29%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 56.02% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
  • The dividend of CRBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP56.02%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

CORBION NV

AMS:CRBN (1/20/2026, 4:15:41 PM)

18.88

-0.34 (-1.77%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31
Earnings (Next)02-26
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.10B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target23.92 (26.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.29%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 16.86
Fwd PE 12.41
P/S 0.85
P/FCF 10.95
P/OCF 6.52
P/B 1.51
P/tB 1.73
EV/EBITDA 7.98
EPS(TTM)1.12
EY5.93%
EPS(NY)1.52
Fwd EY8.06%
FCF(TTM)1.72
FCFY9.13%
OCF(TTM)2.9
OCFY15.34%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.46
PEG (5Y)0.34
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.78
F-Score6
WACC6.64%
ROIC/WACC1.39
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.6%
EPS Next 2Y22.97%
EPS Next 3Y19.62%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.6% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.